HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics Industry Vulnerable As Nagoya Protocol Enters Into Force

This article was originally published in The Rose Sheet

Executive Summary

Launching in October, the Nagoya Protocol on Access and Benefit Sharing and related legislation emerging around the globe will focus regulatory scrutiny on companies researching and developing plants and other genetic resources for commercial applications. The cosmetics industry could be a ready target, an expert says, urging firms to assess their supply chains and ensure that necessary ABS agreements are in place.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel